These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 18060244)
1. [Is stent thrombosis the new Achilles heel of interventional cardiology? State of the Art clinical trials, causes and approaches for prevention]. Grumann T; Diehl P; Bode C; Moser M Hamostaseologie; 2007 Dec; 27(5):344-50. PubMed ID: 18060244 [TBL] [Abstract][Full Text] [Related]
2. [Optimal platelet inhibition after coronary stent implantation. Current status]. Silber S; Hoffmeister HM; Bode C Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073 [TBL] [Abstract][Full Text] [Related]
3. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives. Jaffe R; Strauss BH J Am Coll Cardiol; 2007 Jul; 50(2):119-27. PubMed ID: 17616295 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy in patients undergoing coronary stent implantation: Italian Society of Interventional Cardiology consensus document. Guagliumi G; Musumeci G; Rossini R; Bolognese L; Giordano A; Marzocchi A; Ramondo A; Sangiorgi G; Tamburino C; Tomai F; De Servi S J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):782-91. PubMed ID: 17885515 [TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Lüscher TF; Steffel J; Eberli FR; Joner M; Nakazawa G; Tanner FC; Virmani R Circulation; 2007 Feb; 115(8):1051-8. PubMed ID: 17325255 [TBL] [Abstract][Full Text] [Related]
6. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis? Kumbhani DJ; Bavry AA; Bhatt DL Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427 [TBL] [Abstract][Full Text] [Related]
8. Very late bare-metal stent thrombosis. A case report and review of the literature. Manjappa N; Agarwal A; Cavusoglu E J Invasive Cardiol; 2006 Jul; 18(7):E203-6. PubMed ID: 16816449 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy following drug-eluting stent implantation: new clinical data and recommendations. Paradis JM; Ducrocq G; Tanguay JF Minerva Cardioangiol; 2008 Feb; 56(1):139-54. PubMed ID: 18432176 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives. Ducrocq G; Serebruany V; Tanguay JF Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923 [TBL] [Abstract][Full Text] [Related]
11. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
12. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy. Teirstein P; Reilly JP J Invasive Cardiol; 2002 Mar; 14(3):109-14. PubMed ID: 11870263 [TBL] [Abstract][Full Text] [Related]
13. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation. Yan BP; Gurvitch R; Ajani AE Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822 [TBL] [Abstract][Full Text] [Related]
14. New drug-eluting stent platforms to prevent stent thrombosis. Kereiakes DJ Rev Cardiovasc Med; 2007; 8 Suppl 1():S34-43. PubMed ID: 17401310 [TBL] [Abstract][Full Text] [Related]
15. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents. Spinler SA Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808 [TBL] [Abstract][Full Text] [Related]
16. Very late stent thrombosis after dual antiplatelet therapy discontinuation in a patient with a history of acute stent thrombosis. Bhatt SH; Hauser TH Ann Pharmacother; 2008 May; 42(5):708-12. PubMed ID: 18381843 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study). Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050 [TBL] [Abstract][Full Text] [Related]
18. Thrombosis and drug-eluting stents: an objective appraisal. Holmes DR; Kereiakes DJ; Laskey WK; Colombo A; Ellis SG; Henry TD; Popma JJ; Serruys PW; Kimura T; Williams DO; Windecker S; Krucoff MW J Am Coll Cardiol; 2007 Jul; 50(2):109-18. PubMed ID: 17616294 [TBL] [Abstract][Full Text] [Related]
19. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. Caixeta A; Leon MB; Lansky AJ; Nikolsky E; Aoki J; Moses JW; Schofer J; Morice MC; Schampaert E; Kirtane AJ; Popma JJ; Parise H; Fahy M; Mehran R J Am Coll Cardiol; 2009 Sep; 54(10):894-902. PubMed ID: 19712798 [TBL] [Abstract][Full Text] [Related]
20. Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy. Varghese I; Ummer A; Roesle M; Banerjee S; Brilakis ES Cardiovasc Revasc Med; 2008; 9(3):179-81. PubMed ID: 18606381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]